Literature DB >> 10783821

Intravenous to oral (iv:po) anti-infective conversion therapy.

G A Wetzstein1.   

Abstract

Mesh:

Substances:

Year:  2000        PMID: 10783821     DOI: 10.1177/107327480000700211

Source DB:  PubMed          Journal:  Cancer Control        ISSN: 1073-2748            Impact factor:   3.302


× No keyword cloud information.
  8 in total

Review 1.  Antifungal drugs and rational use of antifungals in treating invasive aspergillosis: the role of the hospital pharmacist.

Authors:  Tiene G M Bauters; Franky M A Buyle; Renaat Peleman; Hugo Robays
Journal:  Pharm World Sci       Date:  2005-02

Review 2.  Methodology in improving antibiotic implementation policies.

Authors:  Onur Özgenç
Journal:  World J Methodol       Date:  2016-06-26

3.  Implementation of guidelines for sequential therapy with fluoroquinolones in a Belgian hospital.

Authors:  Franky Buyle; Dirk Vogelaers; Renaat Peleman; Georges Van Maele; Hugo Robays
Journal:  Pharm World Sci       Date:  2010-04-01

4.  [Preservation of hip prosthesis with local surgical revision and creation of a fistula persistens : an option for palliative treatment of periprosthetic infection in old, polymorbid patients?].

Authors:  A H Tiemann; L Homagk; M Diefenbeck; T Mückley; G O Hofmann
Journal:  Unfallchirurg       Date:  2007-12       Impact factor: 1.000

Review 5.  Switch over from intravenous to oral therapy: A concise overview.

Authors:  Jissa Maria Cyriac; Emmanuel James
Journal:  J Pharmacol Pharmacother       Date:  2014-04

6.  Current Practice and Barriers to an Early Antimicrobial Conversion from Intravenous to Oral among Hospitalized Patients at Jimma University Specialized Hospital: Prospective Observational Study.

Authors:  Alemseged Beyene Berha; Gizat Molla Kassie
Journal:  Interdiscip Perspect Infect Dis       Date:  2019-01-29

7.  Principles of empiric antimicrobial usage and dosing: Lessons learned.

Authors:  Kathryn M Lalonde; Cameron Black; John C Lam
Journal:  Clin Case Rep       Date:  2022-03-17

8.  Intravenous to oral transition of antibiotics for gram-negative bloodstream infection at a University hospital in Thailand: Clinical outcomes and predictors of treatment failure.

Authors:  Titawadee Pradubkham; Gompol Suwanpimolkul; Alan Edward Gross; Chotirat Nakaranurack
Journal:  PLoS One       Date:  2022-09-22       Impact factor: 3.752

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.